Partner Trial
Randomised, phase II/III, 3-stage trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in breast cancer patients with triple negative and/or gBRCA sub-type.
Services
- Ability to recontact
- Access to the full pathology archive
- Human functional tissue assays
- Immunohistochemistry - scoring
- Immunohistochemistry - staining
- Tissue micro array creation
- Nucleic acid extraction
Existing samples:
- Malignant tumor of breast (disorder)
Contact Information
- Email:
- Partner@addenbrookes.nhs.uk
- Address:
-
Cambridge Cancer Trials Centre (S4), Box 279,
Addenbrookes Hospital,
Hills Road,
Cambridge
Cambridgeshire
CB2 0QQ
England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |